Are antiseptic-coated central venous catheters effective in a real-world setting?

American Journal of Infection Control

Volumn 34, Issue 6, 2006, Pages 388-393

  Borschel, Debaroti M ^a,b   Chenoweth, Carol E ^a   Kaufman, Samuel R ^b   Hyde, Kristi Vander ^a   VanDerElzen, Kristen A ^a   Raghunathan, Trivellore E ^a   Collins, Curtis D ^b   Saint, Sanjay ^a,b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CHLORHEXIDINE; SULFADIAZINE SILVER; VANCOMYCIN;

ADULT; ARTICLE; BLOOD FLOW; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CRITICAL ILLNESS; DRUG USE; ECONOMIC ASPECT; HEALTH CARE; HUMAN; INCIDENCE; INFECTION RATE; INTENSIVE CARE UNIT; OUTCOME ASSESSMENT; RISK REDUCTION; STATISTICAL SIGNIFICANCE; TERTIARY HEALTH CARE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; ANTISEPSIS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHLORHEXIDINE; CROSS INFECTION; HOSPITALS, UNIVERSITY; HUMANS; POISSON DISTRIBUTION; REGRESSION ANALYSIS; SEPSIS; SILVER SULFADIAZINE; TREATMENT OUTCOME; VANCOMYCIN;

EID: 33746315629     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2005.08.004     Document Type: Article

References (36)

1. National Nosocomial Infections Surveillance (NNIS) System report, Data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 27 (1999) 520-532
2. Mermel L.A. Prevention of intravascular catheter-related infections. Ann Intern Med 132 (2000) 391-402
3. Pittet D., Tarara D., and Wenzel R.P. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 271 (1994) 1598-1601
4. Collignon P.J. Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 161 (1994) 374-378
5. Safdar N., Kluger D.M., and Maki D.G. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies. Medicine (Baltimore) 81 (2002) 466-479
6. Saint S., Veenstra D.L., and Lipsky B.A. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful?. Infect Control Hosp Epidemiol 21 (2000) 375-380
7. Rello J., Ochagavia A., Sabanes E., Roque M., Mariscal D., Reynaga E., et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 162 (2000) 1027-1030
8. Dimick J.B., Pelz R.K., Consunji R., Swoboda S.M., Hendrix C.W., and Lipsett P.A. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 136 (2001) 229-234
9. Veenstra D.L., Saint S., and Sullivan S.D. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 282 (1999) 554-560
10. Eyer S., Brummitt C., Crossley K., Siegel R., and Cerra F. Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med 18 (1990) 1073-1079
11. Cobb D.K., High K.P., Sawyer R.G., Sable C.A., Adams R.B., Lindley D.A., et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 327 (1992) 1062-1068
12. Nystrom B. Impact of handwashing on mortality in intensive care: examination of the evidence. Infect Control Hosp Epidemiol 15 (1994) 435-436
13. Doebbeling B.N., Stanley G.L., Sheetz C.T., Pfaller M.A., Houston A.K., Annis L., et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 327 (1992) 88-93
14. Maki D.G., Ringer M., and Alvarado C.J. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338 (1991) 339-343
15. Mimoz O., Pieroni L., Lawrence C., Edouard A., Costa Y., Samii K., et al. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med 24 (1996) 1818-1823
16. Veenstra D.L., Saint S., Saha S., Lumley T., and Sullivan S.D. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 281 (1999) 261-267
17. Bach A. Clinical studies on the use of antibiotic- and antiseptic-bonded catheters to prevent catheter-related infection. Zentralbl Bakteriol 283 (1995) 208-214
18. Tennenberg S., Lieser M., McCurdy B., Boomer G., Howington E., Newman C., et al. A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections. Arch Surg 132 (1997) 1348-1351
19. Maki D.G., Stolz S.M., Wheeler S., and Mermel L.A. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 127 (1997) 257-266
20. Logghe C., Van Ossel C., D'Hoore W., Ezzedine H., Wauters G., and Haxhe J.J. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect 37 (1997) 145-156
21. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 16 (1988) 128-140
22. Preventing the Spread of Vancomycin Resistance-A Report from the Hospital Infection Control Practices Advisory Committee prepared by the Subcommittee on Prevention and Control of Antimicrobial-Resistant Microorganisms in Hospitals; comment period and public meeting-CDC. Notice. Federal Register 59 (1994) 25758-25763
23. Pauker S.G. Deciding about screening. Ann Intern Med 118 (1993) 901-902
24. Digiovine B., Chenoweth C., Watts C., and Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 160 (1999) 976-981
25. O'Grady N.P., Alexander M., Dellinger E.P., Gerberding J.L., Heard S.O., Maki D.G., et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 51 (2002) 1-29
26. Stosor V., Peterson L.R., Postelnick M., and Noskin G.A. Enterococcus faecium bacteremia: does vancomycin resistance make a difference?. Arch Intern Med 158 (1998) 522-527
27. Carmeli Y., Samore M.H., and Huskins C. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. Arch Intern Med 159 (1999) 2461-2468
28. Cetinkaya Y., Falk P.S., and Mayhall C.G. Effect of gastrointestinal bleeding and oral medications on acquisition of vancomycin-resistant Enterococcus faecium in hospitalized patients. Clin Infect Dis 35 (2002) 935-942
29. Fridkin S.K., Edwards J.R., Courval J.M., Hill H., Tenover F.C., Lawton R., et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units. Ann Intern Med 135 (2001) 175-183
30. D'Agata E.M., Green W.K., Schulman G., Li H., Tang Y.W., and Schaffner W. Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition. Clin Infect Dis 32 (2001) 23-29
31. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 44 (1995) 1-13
32. Fridkin S.K., Edwards J.R., Pichette S.C., Pryor E.R., McGowan Jr. J.E., Tenover F.C., et al. Determinants of vancomycin use in adult intensive care units in 41 United States hospitals. Clin Infect Dis 28 (1999) 1119-1125
33. Raad I., Darouiche R., Dupuis J., Abi-Said D., Gabrielli A., Hachem R., et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 127 (1997) 267-274
34. Raad I., Darouiche R., Hachem R., Mansouri M., and Bodey G.P. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 173 (1996) 418-424
35. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., and Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 136 (2002) 792-801
36. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., and Saint S. Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine. Clin Infect Dis 37 (2003) 764-771